These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 10490999)

  • 21. The human intracellular interleukin 1 receptor antagonist promoter appropriately regulates gene expression in keratinocytes and gastrointestinal epithelial cells in vivo.
    Gabay C; Smith MF; Arend WP
    Cytokine; 1999 Aug; 11(8):561-70. PubMed ID: 10433802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of intracellular IL-1 receptor antagonist gene by IL-1 alpha in primary mouse keratinocytes.
    La E; Fischer SM
    J Immunol; 2001 May; 166(10):6149-55. PubMed ID: 11342635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV predominantly induces IL-1 receptor antagonist over IL-1 synthesis in human primary monocytes.
    Zavala F; Rimaniol AC; Boussin F; Dormont D; Bach JF; Descamps-Latscha B
    J Immunol; 1995 Sep; 155(5):2784-93. PubMed ID: 7650404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and secretion of interleukin-1 alpha and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes.
    Corradi A; Franzi AT; Rubartelli A
    Exp Cell Res; 1995 Apr; 217(2):355-62. PubMed ID: 7698236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of IL-1 and IL-1 receptor antagonist in HaCaT keratinocytes by tumor necrosis factor-alpha and transforming growth factor-beta 1.
    Kang K; Hammerberg C; Cooper KD
    Exp Dermatol; 1996 Aug; 5(4):218-26. PubMed ID: 8889469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis.
    Powell JJ; Fearon KC; Siriwardena AK; Ross JA
    Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
    Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ
    J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts.
    Kadono T; Kikuchi K; Ihn H; Takehara K; Tamaki K
    J Rheumatol; 1998 Feb; 25(2):296-301. PubMed ID: 9489822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.
    Tilg H; Shapiro L; Vannier E; Poutsiaka DD; Trehu E; Atkins MB; Dinarello CA; Mier JW
    J Immunol; 1994 Mar; 152(6):3189-98. PubMed ID: 8144913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophils process interleukin-1beta and interleukin-18 precursors in a caspase-1-like fashion--processing is inhibited by human vascular smooth muscle cells.
    Westphal E; Herzberg M; Neumann I; Beibei L; Pilowski C; Li C; Werdan K; Loppnow H
    Eur Cytokine Netw; 2006 Mar; 17(1):19-28. PubMed ID: 16613759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.
    Jungo F; Dayer JM; Modoux C; Hyka N; Burger D
    Cytokine; 2001 Jun; 14(5):272-82. PubMed ID: 11444907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease.
    Holmlund A; Hänström L; Lerner UH
    J Clin Periodontol; 2004 Jun; 31(6):475-82. PubMed ID: 15142219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-1 receptor antagonist attenuates MAP kinase/AP-1 activation and MMP1 expression in UVA-irradiated human fibroblasts induced by culture medium from UVB-irradiated human skin keratinocytes.
    Wang X; Bi Z; Chu W; Wan Y
    Int J Mol Med; 2005 Dec; 16(6):1117-24. PubMed ID: 16273295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist.
    Wahl SM; Costa GL; Corcoran M; Wahl LM; Berger AE
    J Immunol; 1993 Apr; 150(8 Pt 1):3553-60. PubMed ID: 8468489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.